FCN3
Basic information
Region (hg38): 1:27369110-27374824
Links
Phenotypes
GenCC
Source:
- immunodeficiency due to ficolin3 deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ficolin 3 deficiency | AR | Allergy/Immunology/Infectious | Sequelae have been described as including frequent and severe infections, and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 19535802 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FCN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 5 | 0 |
Variants in FCN3
This is a list of pathogenic ClinVar variants found in the FCN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-27369253-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
1-27369282-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
1-27369339-C-G | not specified | Uncertain significance (Nov 29, 2023) | ||
1-27369339-C-T | Immunodeficiency due to ficolin3 deficiency | Uncertain significance (Jul 20, 2022) | ||
1-27369342-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
1-27369357-C-G | not specified | Uncertain significance (Jul 13, 2022) | ||
1-27369357-C-T | not specified | Likely benign (Aug 08, 2023) | ||
1-27369372-T-C | Uncertain significance (-) | |||
1-27369386-G-A | Immunodeficiency due to ficolin3 deficiency | Benign/Likely benign (Oct 01, 2022) | ||
1-27369477-C-G | not specified | Uncertain significance (May 10, 2023) | ||
1-27370346-G-T | Rheumatic heart disease | risk factor (Jan 09, 2019) | ||
1-27370605-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
1-27370634-T-C | Immunodeficiency due to ficolin3 deficiency | Uncertain significance (Aug 13, 2019) | ||
1-27370658-C-T | Uncertain significance (Apr 18, 2019) | |||
1-27370659-G-A | not specified | Uncertain significance (Jul 08, 2022) | ||
1-27370667-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
1-27370689-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
1-27370715-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
1-27370854-A-G | not specified | Uncertain significance (Jul 08, 2022) | ||
1-27370861-G-A | not specified | Uncertain significance (Jul 14, 2024) | ||
1-27370868-C-G | not specified • Immunodeficiency due to ficolin3 deficiency | Likely benign (Apr 18, 2022) | ||
1-27370878-A-T | not specified | Uncertain significance (May 08, 2024) | ||
1-27370908-C-T | not specified | Uncertain significance (Sep 29, 2022) | ||
1-27370926-C-A | Immunodeficiency due to ficolin3 deficiency | Uncertain significance (Oct 16, 2019) | ||
1-27370932-C-T | not specified | Uncertain significance (Apr 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FCN3 | protein_coding | protein_coding | ENST00000270879 | 8 | 5713 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00380 | 0.961 | 125306 | 2 | 426 | 125734 | 0.00170 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.422 | 162 | 178 | 0.911 | 0.0000106 | 1922 |
Missense in Polyphen | 55 | 55.073 | 0.99867 | 653 | ||
Synonymous | 1.67 | 50 | 67.4 | 0.742 | 0.00000383 | 598 |
Loss of Function | 1.84 | 6 | 13.2 | 0.454 | 5.64e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00508 | 0.00501 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000695 | 0.000693 |
European (Non-Finnish) | 0.00250 | 0.00248 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000392 | 0.000392 |
Other | 0.00229 | 0.00228 |
dbNSFP
Source:
- Function
- FUNCTION: May function in innate immunity through activation of the lectin complement pathway. Calcium-dependent and GlcNAc- binding lectin. Has affinity with GalNAc, GlcNAc, D-fucose, as mono/oligosaccharide and lipopolysaccharides from S.typhimurium and S.minnesota. {ECO:0000269|PubMed:11907111, ECO:0000269|PubMed:17215869}.;
- Disease
- DISEASE: Ficolin 3 deficiency (FCN3D) [MIM:613860]: A disorder characterized by immunodeficiency, recurrent infections, brain abscesses and recurrent warts on the fingers. Affected individuals have normal levels of lymphocytes, normal T-cell responses, and normal antibodies, but a selective deficient antibody response to pneumococcal polysaccharide vaccine. {ECO:0000269|PubMed:19535802}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Innate Immune System;Immune System;Initial triggering of complement;Ficolins bind to repetitive carbohydrate structures on the target cell surface;Lectin pathway of complement activation;Creation of C4 and C2 activators;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.600
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.0966
- hipred
- N
- hipred_score
- 0.198
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.139
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- complement activation, lectin pathway;proteolysis;complement activation;recognition of apoptotic cell;negative regulation of viral entry into host cell;defense response to virus;negative regulation of RNA biosynthetic process
- Cellular component
- extracellular region;collagen trimer;blood microparticle
- Molecular function
- antigen binding;serine-type endopeptidase activity;protein binding;carbohydrate binding;metal ion binding